| CTRI Number |
CTRI/2025/08/093187 [Registered on: 18/08/2025] Trial Registered Prospectively |
| Last Modified On: |
18/08/2025 |
| Post Graduate Thesis |
Yes |
| Type of Trial |
Observational |
|
Type of Study
|
Follow Up Study |
| Study Design |
Single Arm Study |
|
Public Title of Study
|
study of features of warts to predict how well it responds to standard treatment using a special magnifying lens to find signs that show which warts will improve with treatment |
|
Scientific Title of Study
|
Dermoscopic predictors of treatment response in cutaneous warts: A Prospective Observational Study |
| Trial Acronym |
NIL |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Dr Niveditha Amarnath |
| Designation |
Junior resident |
| Affiliation |
KASTURBA MEDICAL COLLEGE MANIPAL |
| Address |
Room 22
Department of Dermatology, venereology leprosy
OPD Block
Manipal academy of higher education
Madhav Nagar
Manipal
Karnataka
576104
Udupi KARNATAKA 576104 India |
| Phone |
9845551450 |
| Fax |
|
| Email |
niveditha.kmcmpl2024@learner.manipal.edu |
|
Details of Contact Person Scientific Query
|
| Name |
Dr Sathish Pai B |
| Designation |
Professor |
| Affiliation |
Kasturba Medical College, Manipal |
| Address |
Room 22
OPD Block
Department of Dermatology Venereology and Leprosy
Kmc manipal
Manipal academy of higher education
Manipal
karnataka
Udupi KARNATAKA 576104 India |
| Phone |
9900405072 |
| Fax |
|
| Email |
sb.pai@manipal.edu |
|
Details of Contact Person Public Query
|
| Name |
Dr Sathish Pai B |
| Designation |
Professor |
| Affiliation |
Kasturba Medical College, Manipal |
| Address |
Room 22
OPD Block
Department of Dermatology Venereology and Leprosy
Kmc manipal
Manipal academy of higher education
Manipal
karnataka
Udupi KARNATAKA 576104 India |
| Phone |
9900405072 |
| Fax |
|
| Email |
sb.pai@manipal.edu |
|
|
Source of Monetary or Material Support
|
|
|
Primary Sponsor
|
| Name |
Self |
| Address |
Room 22
Departmemt of Dermatology Venereology and Leprosy
Kmc manipal
Manipal academy of higher education
Madhav nagar
Manipal
Karnataka
|
| Type of Sponsor |
Other [Self] |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Niveditha Amarnath |
Kasturba Medical College, Manipal |
Department of dermatology venereology and Leprosy
Room 22
Opd block Udupi KARNATAKA |
9845551450
niveditha.kmcmpl2024@learner.manipal.edu |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| Kasturba Medical College and Kasturba Hospital Institutional Ethics Committee - 2 (Student Research) |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition: B079||Viral wart, unspecified, |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Intervention |
Nil |
Nil |
| Intervention |
Nil |
Nil |
|
|
Inclusion Criteria
|
| Age From |
12.00 Year(s) |
| Age To |
99.00 Year(s) |
| Gender |
Both |
| Details |
Newly diagnosed cutaneous warts
Age older than 12
Common and plantar warts
Undergoing Cryotherapy with parring if required
Using Topical keratolytic such as salicylic acid
Undergoing immunotherapy such as PPD MMR or vitamin D
Combination of these treatments |
|
| ExclusionCriteria |
| Details |
Immunosuppressed patient due to HIV cancer or immunosuppressive medications
Lacking initial or follow up clinical and dermoscopic images
Did not complete the planned treatment |
|
|
Method of Generating Random Sequence
|
Not Applicable |
|
Method of Concealment
|
Not Applicable |
|
Blinding/Masking
|
Not Applicable |
|
Primary Outcome
|
| Outcome |
TimePoints |
| treatment response to therapy suggested by the clinician, which will be evaluated both clinically and through dermoscopic images |
at baseline, and every follow up visit until lesion clearance or 5 follow ups, whichever earlier. |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| how specific dermoscopic features (such as the presence of dots, marked surface scales, and well-defined margins) correlated with these response categories |
First visit and every follow up until 5 visits or lesion clearance |
|
|
Target Sample Size
|
Total Sample Size="120" Sample Size from India="120"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
N/A |
|
Date of First Enrollment (India)
|
29/08/2025 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="2" Months="0" Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Applicable |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
|
Brief Summary
|
This study aims to determine whether dermoscopic features such as vascular patterns surface scale characteristics and margin definition can predict treatment outcomes in cutaneous warts. The study involves capturing standardized clinical and dermoscopic images before and after treatment including cryotherapy with parring and immunotherapy with intralesional PPD MMR and vitamin D. Topical keratolytic like salicylic acid application in between each of the follow ups will also be included. Each lesions will be followed for five visits or until lesion clearance whichever occurs earlier. Dermoscopic findings will be classified and correlated with treatment response. The objective is to validate dermoscopy as a predictive tool to improve treatment planning and minimize unnecessary sessions. The study addresses the current challenge of variable treatment response and aims to optimize patient care. |